Thomas Jefferson University

Stephanie Nahas

TitleProfessor
InstitutionThomas Jefferson University
DepartmentNeurology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-955-2031
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lipton RB, Nahas SJ, Pozo-Rosich P, Bilchik T, McAllister P, Finnegan M, Liu Y, Chalermpalanupap N, Dabruzzo B, Dodick DW. Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial. J Headache Pain. 2024 May 21; 25(1):83. PMID: 38773375.
      Citations:    
    2. Nahas SJ. Cranial Neuralgias. Continuum (Minneap Minn). 2024 Apr 01; 30(2):473-487. PMID: 38568494.
      Citations:    
    3. Rizzoli P, Marmura MJ, Robblee J, McVige J, Sacco S, Nahas SJ, Ailani J, De Abreu Ferreira R, Ma J, Smith JH, Dabruzzo B, Ashina M. Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials. J Headache Pain. 2024 Mar 11; 25(1):35. PMID: 38462625.
      Citations:    
    4. Tassorelli C, Onishchenko K, Halker Singh RB, Duan M, Dupont-Benjamin L, Hemstock M, Voller C, McAllister P, Nahas SJ, Gandhi P, Ailani J. Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis. Cephalalgia. 2024 Feb; 44(2):3331024241235156. PMID: 38410850.
      Citations:    
    5. Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, L?f E, Brevig T, Cady R, Diener HC. Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol. 2023 Aug 24. PMID: 37615752.
      Citations:    
    6. Charleston L, Talon B, Sullivan C, Anderson C, Kymes S, Regnier SA, Soni-Brahmbhatt S, Nahas SJ. Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study. J Headache Pain. 2023 Aug 02; 24(1):101. PMID: 37532991.
      Citations:    
    7. Ailani J, Nahas SJ, Friedman DI, Kunkel T. The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review. Pain Ther. 2023 Apr 24. PMID: 37093356.
      Citations:    
    8. Buse DC, Nahas SJ, Stewart WBF, Armand CE, Reed ML, Fanning KM, Adams AM, Lipton RB. OPTIMIZED ACUTE TREATMENT OF MIGRAINE IS ASSOCIATED WITH GREATER PRODUCTIVITY IN PEOPLE WITH MIGRAINE: RESULTS FROM THE CHRONIC MIGRAINE EPIDEMIOLOGY AND OUTCOMES (CAMEO) STUDY. J Occup Environ Med. 2023 Jan 25. PMID: 36701797.
      Citations:    
    9. Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Correction: Efficacy and safety of fremanezumab in clinical trial participants aged =60?years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies. J Headache Pain. 2022 May 17; 23(1):57. PMID: 35581545.
      Citations:    
    10. Tepper SJ, Sheikh HU, Dougherty CO, Nahas SJ, Winner PK, Karanam AK, Blumenfeld AM, Abdrabboh A, Rasmussen S, Weiss JL, Ailani J. Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations. Headache. 2022 Feb 09. PMID: 35137404.
      Citations:    
    11. Mojica JJ, Schwenk ES, Lauritsen C, Nahas SJ. Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine. Curr Pain Headache Rep. 2021 Dec 11; 25(12):77. PMID: 34894295.
      Citations:    
    12. Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Efficacy and safety of fremanezumab in clinical trial participants aged =60?years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies. J Headache Pain. 2021 Nov 24; 22(1):141. PMID: 34819017.
      Citations:    
    13. Nahas SJ. Cluster Headache and Other Trigeminal Autonomic Cephalalgias. Continuum (Minneap Minn). 2021 06 01; 27(3):633-651. PMID: 34048396.
      Citations:    
    14. Nahas SJ, Hindiyeh N, Friedman DI, Elbuluk N, Kellerman DJ, Foreman PK, Schmidt P. Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine. J Headache Pain. 2021 May 17; 22(1):37. PMID: 34001002.
      Citations:    
    15. Yan BM, Gibson Depoy EM, Ahmad A, Nahas SJ. Biomarkers in Migraine. Neurol India. 2021 Mar-Apr; 69(Supplement):S17-S24. PMID: 34003145.
      Citations:    
    16. Flores-Montanez Y, Nahas SJ. Unusual Brain MRI Findings in Patients Imaged for Headache: a Case Series. Curr Pain Headache Rep. 2020 Jul 20; 24(9):51. PMID: 32691182.
      Citations:    
    17. Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ. Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations. J Pain Res. 2020; 13:859-864. PMID: 32431533.
      Citations:    
    18. Minen MT, Robbins MS, Loder E, Nahas S, Gautreaux J, Litin S, Barch C, Cook C, Smith T, Powers SW, Hasan S, Sbar E, Stika CS, Stone F, Sprouse-Blum A. Addressing the Crisis of Diagnosis and Management of Migraine in Primary Care: A Summary of the American Headache Society FrontLine Primary Care Advisory Board. Headache. 2020 Apr 08. PMID: 32267961.
      Citations:    
    19. Burkett JG, Nahas SJ. Correction to: Diving Headache. Curr Pain Headache Rep. 2019 08 10; 23(10):77. PMID: 31401697.
      Citations:    
    20. Burkett JG, Nahas SJ. Diving Headache. Curr Pain Headache Rep. 2019 05 30; 23(7):46. PMID: 31147799.
      Citations:    
    21. Wilhour D, Ceriani CEJ, Nahas SJ. Nummular Headache. Curr Neurol Neurosci Rep. 2019 Apr 17; 19(6):26. PMID: 30997617.
      Citations:    
    22. Wilhour D, Nahas SJ. The Neuralgias. Curr Neurol Neurosci Rep. 2018 Aug 16; 18(10):69. PMID: 30116913.
      Citations:    
    23. Kumpinsky A, Nahas SJ. Bath-Related Headache. Curr Pain Headache Rep. 2018 Aug 02; 22(10):68. PMID: 30073574.
      Citations:    
    24. Ceriani CEJ, Nahas SJ. Exploding Head Syndrome: a Review. Curr Pain Headache Rep. 2018 Jul 30; 22(10):63. PMID: 30062616.
      Citations:    
    25. Lauritsen CG, Chua AL, Nahas SJ. Current Treatment Options: Headache Related to Menopause-Diagnosis and Management. Curr Treat Options Neurol. 2018 Mar 06; 20(4):7. PMID: 29508091.
      Citations:    
    26. Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine Infusions for Treatment Refractory Headache. Headache. 2017 Feb; 57(2):276-282. PMID: 28025837.
      Citations:    
    27. Zhu S, Nahas SJ. CADASIL: Imaging Characteristics and Clinical Correlation. Curr Pain Headache Rep. 2016 Oct; 20(10):57. PMID: 27591799.
      Citations:    
    28. Chua AL, Nahas S. Ice Pick Headache. Curr Pain Headache Rep. 2016 May; 20(5):30. PMID: 27038969.
      Citations:    
    29. Pomeroy JL, Nahas SJ. SUNCT/SUNA: A Review. Curr Pain Headache Rep. 2015 Aug; 19(8):511. PMID: 26092511.
      Citations:    
    30. Nahas SJ. Patient Management Problem-Preferred Responses. Continuum (Minneap Minn). 2015 Aug; 21(4 Headache):1220-9. PMID: 26252609.
      Citations:    
    31. Nahas SJ. Patient Management Problem. Continuum (Minneap Minn). 2015 Aug; 21(4 Headache):1214-9. PMID: 26252608.
      Citations:    
    32. Goldberg SW, Nahas SJ. Supratrochlear and Supraorbital Nerve Stimulation for Chronic Headache: a Review. Curr Pain Headache Rep. 2015 Jul; 19(7):496. PMID: 26049769.
      Citations:    
    33. Nahas SJ. Headache and temporal arteritis: when to suspect and how to manage. Curr Pain Headache Rep. 2012 Aug; 16(4):371-8. PMID: 22552735.
      Citations:    
    34. Gupta S, Nahas SJ, Peterlin BL. Chemical mediators of migraine: preclinical and clinical observations. Headache. 2011 Jun; 51(6):1029-45. PMID: 21631491.
      Citations:    
    35. Nahas SJ. Diagnosis of acute headache. Curr Pain Headache Rep. 2011 Apr; 15(2):94-7. PMID: 21286867.
      Citations:    
    36. Solomon M, Nahas SJ, Segal JZ, Young WB. Medication adaptation headache. Cephalalgia. 2011 Apr; 31(5):515-7. PMID: 21059629.
      Citations:    
    37. Marmura MJ, Nahas SJ. What might the ideal electronic medical record for migraine headache look like? Curr Pain Headache Rep. 2010 Jun; 14(3):233-7. PMID: 20425192.
      Citations:    
    38. Nahas SJ, Silberstein SD. Triptans: actions and reactions. Headache. 2008 Apr; 48(4):611-3. PMID: 18377383.
      Citations:    
    Nahas's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (66)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _